Early believers
Long-term partners

Why choose us?

01

We value openness and trust

We aim to be transparent in how we invest, assess and collaborate. We show up in the ecosystem and share our thinking openly, and we expect the same openness and trust from the founders we partner with.

02

We respect your time and move fast

Your time matters. We keep our structure lean so we can respond quickly with clear answers and respect for your focus on building.

03

We’re built for the long run

Scaling research-based businesses takes time, courage and capital. With our evergreen structure, we can support your company from pre-seed to the growth stage as a consistent partner on the journey.

Show us what you’re building

As an evergreen fund, we are built to be a long-term partner. We invest from pre-seed through Series B, backing founders solving real-world challenges. If this sounds like you, share your pitch deck.

Our team

We combine experience, network and dedication with a genuine curiosity for the people behind the ideas. We care deeply about ideas that can make a real difference in the world.

What we invest in

  • Sectors: Food, Health, Defence and Energy
  • Stage: Pre-seed
  • Initial ticket: EUR 100k–1m
  • Follow-on: Reserve capital through Series B
  • Max investment: Up to EUR 10m per company

Danish biotech startup Alcolase wants to tackle hidden health problem affecting 540 million people globally

Read more

Derfor afslører Delphinus ikke størrelsen på sine investeringer

Read more

Ardos brings real-time dose verification to radiotherapy

Read more

Ny fond øremærker 85 pct. af puljen til opfølgende investeringer

Read more

From coastal nuisance to feed ingredient: Decameal raises seed round to valorise invasive shore crabs

Read more

EtOH Spirits secures investment to scale accelerated maturation technology for spirits

Read more

From a childhood dream to technology for acute stroke care

Read more

Kvantify announces second close of funding round totalling €7M to accelerate the quantum revolution in drug discovery

Read more

REDUCED raises €4m Series A extension to industrialise fermentation-based flavour platform

Read more

Postpartum complications affect thousands of women – Danish MedTech startup offers a solution

Read more

Novonesis alumni raise capital to make the world healthier with fibre

Read more

Urologist leaves clinical practice to solve an overlooked challenge in bladder cancer

Read more

Cordulus secures €6.8M in Series A funding to expand its AI weather solutions into the energy market

Read more

Delphinus Capital-CEO: ”Jeg har allergi over for startup-lingo og lånte fjer”

Read more

New venture fund to boost knowledge-intensive startups with over half a billion

Read more

Press release about Delphinus Venture Capital

Read more

Delphinus Venture Capital etablerer sig i INCUBA

Read more

Delphinus Venture Capital: New ambitions for Aarhus startups

Read more